Kymera Therapeutics (KYMR)
Develops oral protein degraders for immunology and partnered oncology programs.
$114.83
vs last close−7.23 (−5.92%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | ≈ 116.89% | 97.19M shares | |
|---|---|---|---|
| 293 holders · as of Jun 30, 2026 · largest filers plus last quarter's tail | |||
| Insiders | 1.55% | 1.29M shares | |
| 9 holders · as of Sep 4, 2026 | |||
| Strategic holders | 0.38% | 318.9K shares | |
| 1 holder · as of Jun 26, 2026 | |||
| Adds to | 118.82% | ||
83.15M company shares as of Sep 23, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
This quarter's institutional total failed a plausibility check; shown: the largest filers plus last quarter's remainder.
These groups come from separate filings that can overlap, so they add to 118.82%; nothing is left for Other.
13F, as of Jun 30, 2026
293 holders · 97.19M shares · 56 new positions · 155 increased · 83 reduced · 27 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| FMR LLC | 12.35M | 14.85% | +649.3K | Aug 13, 2026 |
| Baker Bros. Advisors LP | 8.66M | 10.41% | 0 | Aug 14, 2026 |
| Avoro Capital Advisors LLC | 7.47M | 8.99% | 0 | Aug 14, 2026 |
| Price T Rowe Associates Inc /MD/ | 7.11M | 8.55% | +1.05M | Aug 14, 2026 |
| T. Rowe Price Investment Management, Inc. | 6.26M | 7.53% | +792.3K | Aug 14, 2026 |
| BlackRock, Inc. | 5.54M | 6.66% | +477.3K | Aug 7, 2026 |
| BVF Inc/IL | 3.87M | 4.66% | −1.63M | Aug 14, 2026 |
| Wellington Management Group LLP | 3.68M | 4.42% | −214.7K | Aug 14, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| FMR LLC | 14.30% | 11.68M | 13G | May 6, 2026 |
| Baker Bros. Advisors (GP) LLCincl. Felix J. Baker, Baker Bros. Advisors LP +1 more | 10.90% | 8.68M | 13D | Dec 11, 2025 |
| T. Rowe Price Associates, Inc. | 10.70% | 8.87M | 13G | Sep 8, 2026 |
| T. Rowe Price Investment Management, Inc. | 6.70% | 5.46M | 13G | May 15, 2026 |
| BlackRock, Inc. | 5.40% | 3.80M | 13G | Jul 17, 2025 |
Form 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Sep 4, 2026 | Brian Adamsofficer: Chief Legal Officer | Sale · 3 lots | 6,371 | $116.83 | 50,254 |
| Jul 7, 2026 | Nello Mainolfidirector, officer: Chief Executive Officer | Sale | 50,000 | $119.00 | 666,568 |
| Jun 29, 2026 | Bruce Boothdirector | Sale · 28 lots | 153,300 | $108.05 | 461,794 |
| Jul 1, 2026 | Nello Mainolfidirector, officer: Chief Executive Officer | Sale · 5 lots | 80,000 | $115.29 | 666,568 |
| Jul 1, 2026 | Noah Goodmanofficer: Chief Business Officer | Sale | 3,389 | $114.29 | 47,179 |
| Jun 30, 2026 | Bruce N. Jacobsofficer: Chief Financial Officer | Sale · 8 lots | 77,109 | $114.96 | 244,883 |
| Jun 26, 2026 | Bruce Boothdirector | Sale · 24 lots | 467,878 | $110.29 | 472,267 |
| Jun 26, 2026 | BVF Partners L P/ILdirector, other: See Remarks and Footnotes | Sale · 4 lots | 1,630,658 | $106.50 | 318,910 |
| Jun 25, 2026 | Noah Goodmanofficer: Chief Business Officer | Sale · 2 lots | 5,000 | $114.00 | 50,195 |
| Jun 25, 2026 | Bruce Boothdirector | Sale · 46 lots | 548,321 | $118.76 | 529,718 |
House and Senate disclosures
Not reported.